Uncategorized Archives - Page 212 of 248

WednesdayJan 24, 2018 1:56 pm

ChineseInvestors.com, Inc. (CIIX) Plans To Expand and Make a Lasting Impact in the Coming Year

CIIX has created a Yelp-style app for marijuana dispensaries and cannabis strains to help it achieve big goals in 2018 CIIX is committed to forward movement toward a cure for epilepsy Company is expanding its market reach in the U.S., Canada and China through hemp-based products ChineseInvestors.com, Inc.’s (OTCQB: CIIX) mission is to become the leading publicly traded company targeting Chinese medicinal marijuana. Offering a variety of investor education products and services, Warren Wang, CEO and founder, would like to see 2018 bring with it double the revenue and expanded business. One of the ways CIIX is tackling this goal is…

TuesdayJan 23, 2018 3:47 pm

Grey Cloak Tech’s (GRCK) Recent Eqova Acquisition Positions the Company for Growth on Booming CBD Market

Hemp-derived cannabidiol (CBD) sales projected to surpass $1 billion in five years Grey Cloak Tech has acquired Eqova Life Sciences, an established producer of a range of clinical-grade CBD products This acquisition strengthens Grey Cloak’s position in this market sector and is likely to accelerate its growth On the back of several forecasts of explosive growth in the cannabidiol (CBD) market, Grey Cloak Tech, Inc. (OTCQB: GRCK) has made a strategic decision to focus its efforts in this sector. The Hemp Business Journal reports projected growth of 700 percent by 2020, to reach annual sales of $2.1 billion, according to…

TuesdayJan 23, 2018 1:07 pm

Disrupting Drug Delivery Platform Keeps Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) Portfolio Growing

Patented technology promotes healthier administration of active pharmaceutical ingredients, including cannabidiol (CBD), psychoactive cannabinoids (THC), nicotine, fat soluble vitamins and nonsteroidal anti-inflammatory drugs Active pharmaceutical ingredient market expected to exceed $239 billion by 2025 19 patent applications filed in U.S. and internationally encompassing 44 countries Lab tests in 2018 include topical CBD skin cream, nicotine in edible formats Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a research-driven company that has developed and out-licenses a patented drug delivery platform called DehydraTECH™ that changes the way active pharmaceutical ingredients (“APIs”) enter the body orally. According to a new report by Million…

MondayJan 22, 2018 3:17 pm

Skinvisible, Inc. (SKVI) Set to Repeat Olympic Performance in 2018 with DermSafe

Targeting $80 billion global skincare and dermatology market Revenues to be derived from royalties and other licensing fees DermSafe sales have taken off in Greater China Pending merger will expand product offerings Among the winners at the 2016 Summer Olympics in Rio was DermSafe® from Skinvisible’s (OTCQB: SKVI) subsidiary, Kintari. Donated to Team Canada, the non-alcohol hand sanitizing lotion offered protection from pathogens to athletes during the Olympic Games. Now, with the Winter Olympics to be held in South Korea from February 8-25, the need is more pressing. Reported outbreaks of the flu have increased dramatically this year, according to…

MondayJan 22, 2018 12:34 pm

ChineseInvestors.com, Inc. (CIIX) Sees Bright Future for Cryptocurrencies in China

Warren Wang, CEO of CIIX, says trading is active for cryptocurrencies in China on over-the-counter exchanges CIIX doubles down on its commitment to bitcoin and other cryptocurrencies, spinning off two other corporate divisions to spend more time on building its new cryptocurrency division The company’s goal is to gain revenue, profitability and value for its shareholders ChineseInvestors.com, Inc. (OTCQB: CIIX) sees a bright future for cryptocurrencies in China due to interest among Chinese investors in making cryptocurrencies part of their portfolios of assets (http://cnw.fm/kCt9V). Warren Wang, CEO of CIIX, said in a news release that the emerging middle class in…

FridayJan 19, 2018 12:27 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Combining Nature and Science to Make Life Better

Company utilizing novel Caribbean blue scorpion venom therapy for immune system boost PreveCeutical seeks new ways to treat cancers, metabolic disorders, pain, infectious diseases and cardiovascular disease Partnership with University of Queensland researchers advances scientific scope of projects In the modern health care industry, disease prevention has taken a commanding role as screenings and regularly scheduled physician visits aim to minimize costs that could otherwise spiral out of control once a chronic condition is established. However, the Centers for Disease Control and Prevention report an ongoing concern that Americans are using preventive services at about half the recommended rate (http://cnw.fm/OIa4V).…

FridayJan 19, 2018 11:26 am

Proposed Merger Expands Skinvisible, Inc. (SKVI) Horizons into Multi-Billion Dollar Pain Market

Company has developed and licensed novel drug delivery systems and products for over 15 years With 14 patents, Skinvisible has proven efficacy and global reach Proposed merger may transform non-opioid pain market At the cutting edge of innovative drug delivery technology since 1999, Skinvisible, Inc. (OTCQB: SKVI), in a recently announced Letter of Intent of a proposed merger with Quoin Pharmaceuticals, is now expanding its horizons into the global pain management therapeutics market. The pain management therapeutics market is projected to expand at a 3.7 percent CAGR and exceed $83 billion in the United States by 2024 (http://cnw.fm/pEyK9). Skinvisible, through…

WednesdayJan 17, 2018 3:04 pm

Earth Science Tech, Inc. (ETST) Caps a Year of Achievement by Doubling Revenues

Portfolio of hemp-derived CBD products Opening of new production facilities New subsidiaries, acquisitions and joint ventures Earth Science Tech, Inc. (OTC: ETST) is celebrating another year of accomplishment. In 2017, the company churned out a series of advancements that included the launch of new subsidiaries and products and an acquisition, along with entry into marketing, manufacturing and distribution agreements. It also commenced pre-launch human trials of a new product designed to join the fight against opioid addiction. As a result, 2017 revenues were almost twice as much as in 2016. Now, even though the stock is trading at around $1.00,…

WednesdayJan 17, 2018 2:19 pm

Medical Cannabis Payment Solutions (REFG) Breaking the Cannabis Payment Logjam

State-sanctioned cannabis businesses forced into cash-only operations due to federal conundrum Medical Cannabis Payment Solutions has alternative for cannabis banking that solves cash handling issues Company’s proprietary system breaks logjam and provides businesses with competitive advantages As the scientific evidence of the medical efficacy of marijuana has mounted, multiple states have begun to legalize its use. Ignoring antiquated federal strictures, 29 states now permit medicinal use, with eight states allowing recreational use, and more states are expected to expand legalization this coming year. The acceptance of marijuana throughout the nation has spawned a multi-billion dollar industry, yet it has also…

WednesdayJan 17, 2018 1:17 pm

ChineseInvestors.com, Inc. (CIIX) Boosts Investor Relations Revenue, Eyes Profitability in FY2018

CIIX records sharply higher investor relations revenue in 1Q2018 and FY2017 as it expands program offerings for branding clients In FY2018, company will focus on new cryptocurrency division as it increases commitment to bitcoin education and hosts bitcoin ATM in lobby of its San Gabriel, California, headquarters Warren Wang, CEO of CIIX, sets goal of profitability in FY2018 ChineseInvestors.com, Inc. (OTCQB: CIIX) remains diverse, but it has realigned and set a goal of profitability in FY2018 as it increases its core investor relations revenues and offerings while reaffirming its educational services in its cryptocurrency division and its commitment to bitcoin…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

Category: Uncategorized